The invention relates to a traditional Chinese medicine composition for treating a chronic obstructive pulmonary disease. The traditional Chinese medicine composition is prepared from the following drugs: ephedra, ligusticum wallichii, radix angelicae pubescentis, notopterygium root, stephania terandra, liquorice, almond, cinnamon, monkshood, tuckahoe, cimicifugae foetidae, asarum, ginseng, radices sileris, plaster stone, white atractylodes rhizome, angelica sinensis, root of common peony, gastrodia elata, stiff silkworm, scorpio, pinellia ternate, reddish orange, radix asteris, radix bupleuri, root bark of the peony tree, radices trichosanthis, semen coicis, semen brassicae, common hogfennei root, cynanchum glaucescens, tabasheer, Chinese fevervine herb and root, rhodiola rosea, folium ginkgo, fructus psoraleae and astragalus membranaceus. The medicine disclosed by the invention has a significant effect on the chronic obstructive pulmonary disease caused by various reasons, and can be applied to treatment of the chronic obstructive pulmonary disease at an acute stage and catabasis. The medicine disclosed by the invention has a significant clinical treatment effect by years of research, the recovery rate is 64.9%, and the total effective rate is 96.1%. The composite drug composition for treating the chronic obstructive pulmonary disease disclosed by the invention has the characteristics of being good in curative effect, short in treatment course, thorough to treat, free of toxic and side effects and the like, and has obvious effects of improving symptoms and signs of chronic obstructive pulmonary disease (COPD), increasing pulmonary ventilation and regulating the immunologic function.